SPECIALISED Therapeutics has announced the relaunch of Gelclair in Australia, under license from Swiss firm Helsinn Healthcare SA.
Gelclair is used to relieve the pain of oral mucositis, a condition that can affect cancer patients undergoing chemotherapy and/or radiotherapy.
It's a bio-adherent oral gel that creates a protective film in the mouth, and has not been available here since 2015 - for more details see www.STAbiopharm.com.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Apr 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Apr 17
